Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

23. Overview of all interventions in the Patient Global Impression of Change much/very much improved analysis.

Treatment RCTs Participants
Antidepressants with ≥ 200 participants
Desvenlafaxine high dose 1 402
Duloxetine high dose 2 287
Duloxetine standard dose 3 481
Esreboxetine high dose 1 275
Esreboxetine standard dose 1 536
Milnacipran high dose 3 1065
Milnacipran standard dose 3 1043
Antidepressants with < 200 participants (excluded from summaries)
Desvenlafaxine standard dose 1 131
Milnacipran dose unable to be categorised 1 79
RCT: randomised controlled trial
Participant numbers reflect the total number of participants receiving the antidepressant.